Gateway Analytical Growth Demands Move to a Larger Facility
Gateway Analytical announced today that the...
Monitoring Degree of Agglomeration in Aqueous Suspensions Subjected to Various Environmental Conditions by Raman Imaging
Outsourcing the development and manufacturing...
2018 PDA Annual Meeting: A Proactive Approach to the Particulate Management Lifecycle in Parenteral Drug Products
Authors & ContributorsDavid Exline, Cara Plese
Gateway Analytical Receives ISO 17025:2005 Accreditation from the American Association for Laboratory Accreditation
PITTSBURGH, PA – Gateway Analytical announced...
2014 ASSA International IWPCPS-16 Workshops: Spatially-Resolved Raman Imaging for Ingredient-Specific Characterization of Combination Dry Powder Inhalers
June 17, 2014 Since the approval of Dry Powder Inhalers containing Fluticasone Propionate and Salmeterol Xinafoate in 1999, combination inhaled therapies have dominated the COPD market. However, due to the lack of specific guidance of the Office of Generic Drugs as to the abbreviated new drug application submission, there was…
Shedding Light on the Utility of FTIR vs. Raman Spectroscopy
Read Gateway Analytical's piece on shedding light on the utility of FTIR vs. Raman spectroscopy.
What is Pharmaceutical Forensics?
Watch Gateway Analytical's Dave Exline discuss our pharmaceutical forensics services.
Comparison of Raman and FTIR Spectroscopy: Advantages and Limitations
Authors & Contributors David Exline October 09, 2013
2018 RDD Conference: Analysis of a Dry Powder Inhaler Active Pharmaceutical Ingredient Using Scanning Electron Microscopy
Download our presentation from 2018 RDD Conference on Analysis of a Dry Powder Inhaler Active Pharmaceutical Ingredient Using Scanning Electron Microscopy.